Literature DB >> 28924244

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.

S Jo1, J H Lee2,3, J J Mattei2,3, D M Barrett2,3, P van den Elzen4, S A Grupp2,3, G S D Reid1,4, A E Seif2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28924244     DOI： 10.1038/leu.2017.290

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Preleukemic TEL-AML1-positive clones at cell level of 10(-3) to 10(-4) do not persist into adulthood.

Authors:  Marianne Olsen; Hans O Madsen; Henrik Hjalgrim; Jannie Gregers; Klaus Rostgaard; Kjeld Schmiegelow
Journal:  J Pediatr Hematol Oncol       Date:  2006-11       Impact factor: 1.289

2.  Is autoimmunity the Achilles' heel of cancer immunotherapy?

Authors:  Carl H June; Jeremy T Warshauer; Jeffrey A Bluestone
Journal:  Nat Med       Date:  2017-05-05       Impact factor: 53.440

3.  Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.

Authors:  Elena Sotillo; David M Barrett; Kathryn L Black; Asen Bagashev; Derek Oldridge; Glendon Wu; Robyn Sussman; Claudia Lanauze; Marco Ruella; Matthew R Gazzara; Nicole M Martinez; Colleen T Harrington; Elaine Y Chung; Jessica Perazzelli; Ted J Hofmann; Shannon L Maude; Pichai Raman; Alejandro Barrera; Saar Gill; Simon F Lacey; Jan J Melenhorst; David Allman; Elad Jacoby; Terry Fry; Crystal Mackall; Yoseph Barash; Kristen W Lynch; John M Maris; Stephan A Grupp; Andrei Thomas-Tikhonenko
Journal:  Cancer Discov       Date:  2015-10-29       Impact factor: 39.397

4.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

5.  Prenatal origin of acute lymphoblastic leukaemia in children.

Authors:  J L Wiemels; G Cazzaniga; M Daniotti; O B Eden; G M Addison; G Masera; V Saha; A Biondi; M F Greaves
Journal:  Lancet       Date:  1999-10-30       Impact factor: 79.321

6.  Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Authors:  David M Barrett; Alix E Seif; Carmine Carpenito; David T Teachey; Jonathan D Fish; Carl H June; Stephan A Grupp; Gregor S D Reid
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

7.  Chromosome translocations and covert leukemic clones are generated during normal fetal development.

Authors:  Hiroshi Mori; Susan M Colman; Zhijian Xiao; Anthony M Ford; Lyn E Healy; Craig Donaldson; Jill M Hows; Cristina Navarrete; Mel Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

8.  Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

Authors:  Gregory L Beatty; Andrew R Haas; Marcela V Maus; Drew A Torigian; Michael C Soulen; Gabriela Plesa; Anne Chew; Yangbing Zhao; Bruce L Levine; Steven M Albelda; Michael Kalos; Carl H June
Journal:  Cancer Immunol Res       Date:  2014-02       Impact factor: 11.151

9.  The evolution of B precursor leukemia in the Emu-ret mouse.

Authors:  R Wasserman; X X Zeng; R R Hardy
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962
View more
  2 in total

1.  Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.

Authors:  Haiying Qin; Kazusa Ishii; Sang Nguyen; Paul P Su; Chad R Burk; Bong-Hyun Kim; Brynn B Duncan; Samikasha Tarun; Nirali N Shah; M Eric Kohler; Terry J Fry
Journal:  Blood       Date:  2018-09-12       Impact factor: 22.113

2.  Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists.

Authors:  Sumin Jo; Abbas Fotovati; Jesus Duque-Afonso; Michael L Cleary; Peter van den Elzen; Alix E Seif; Gregor S D Reid
Journal:  Cancers (Basel)       Date:  2020-01-10       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.